La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Elevance Health Salute del bilancio
Salute finanziaria criteri di controllo 4/6
Elevance Health ha un patrimonio netto totale di $42.3B e un debito totale di $27.7B, che porta il suo rapporto debito/patrimonio netto a 65.5%. Le sue attività totali e le sue passività totali sono rispettivamente $113.0B e $70.7B. L'EBIT di Elevance Health è $10.5B rendendo il suo rapporto di copertura degli interessi 9.9. Ha liquidità e investimenti a breve termine pari a $36.0B.
Informazioni chiave
71.8%
Rapporto debito/patrimonio netto
US$30.39b
Debito
| Indice di copertura degli interessi | 9.9x |
| Contanti | US$35.99b |
| Patrimonio netto | US$42.30b |
| Totale passività | US$70.69b |
| Totale attività | US$112.99b |
Aggiornamenti recenti sulla salute finanziaria
Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16
Is Elevance Health (NYSE:ELV) A Risky Investment?
Jan 02These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely
Oct 04Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly
Jul 05We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt
Apr 04Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 28Recent updates
Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)
Sep 11Elevance Health: Strong Earnings Growth Supports Strong Dividend Growth
Sep 06There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital
Aug 29Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching
Aug 02Elevance Health: Healthcare Services Segment Is Gaining Traction
Jul 31Elevance Health: Buy A Dividend Growth Machine
Jul 18Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)
Jun 28Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Jun 11Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
May 27We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation
May 09Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63
Apr 25Elevance Health: It's Not Too Late To Buy Their Dividend Growth
Apr 23Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16Elevance Health: Not Doing Enough In 2024 To Justify Premium Price
Apr 11Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors
Apr 01Elevance: A Healthy Dose Of Dividend Growth
Mar 21Elevance Heath: Financial Growth And Technical Strength Indicate A Buy
Mar 07Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63
Feb 19Elevance Health: Time To Buy This Incredible Dividend Growth Stock
Jan 26Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement
Jan 19Is Elevance Health (NYSE:ELV) A Risky Investment?
Jan 02Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story
Dec 18A Look At Elevance's Margin Dynamics
Nov 23Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?
Nov 16Elevance Health: A High Conviction Defensive Blue Chip Buy
Oct 19These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely
Oct 04Elevance: Pave The Way For The Next UnitedHealth
Sep 21Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Sep 18Here's The Price I Would Buy Elevance Health Stock
Sep 13If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity
Aug 18Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
Aug 04Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental
Jul 24Elevance Health: Beaten Down Share Price Offers Solid Potential
Jul 10Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly
Jul 05Elevance Health: A Critical Update (Rating Downgrade)
Jun 05Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
Jun 04Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
May 05We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt
Apr 04Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48
Feb 17Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Feb 13Elevance Health: Attractive On Its Expansion Catalysts
Feb 09Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48
Jan 28Elevance Health acquiring Blue Cross and Blue Shield of Louisiana
Jan 23Elevance Health Offers Great Value
Jan 17At US$483, Is Elevance Health Inc. (NYSE:ELV) Worth Looking At Closely?
Jan 17Elevance Health: Strong And Steady EPS Growth Ahead, High Relative Strength Name
Jan 02Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 28Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( $62.3B ) di ELV superano le sue passività a breve termine ( $41.8B ).
Passività a lungo termine: Le attività a breve termine di ELV ( $62.3B ) superano le sue passività a lungo termine ( $28.9B ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: ELV ha più liquidità del suo debito totale.
Riduzione del debito: Il rapporto debito/patrimonio netto di ELV è aumentato da 64.5% a 65.5% negli ultimi 5 anni.
Copertura del debito: Il debito di ELV non è ben coperto dal flusso di cassa operativo ( 7.5% ).
Copertura degli interessi: I pagamenti degli interessi sul debito di ELV sono ben coperti dall'EBIT ( 9.9 x copertura).